Xeris Biopharma Holdings, Inc.·4

Sep 15, 5:33 PM ET

McCulloch Kevin 4

4 · Xeris Biopharma Holdings, Inc. · Filed Sep 15, 2025

Insider Transaction Report

Form 4
Period: 2025-09-11
McCulloch Kevin
See Remarks
Transactions
  • Other

    Common Stock

    2025-09-112,0000 total(indirect: By Trust)
Holdings
  • Common Stock

    (indirect: By Spouse)
    25,000
  • Common Stock

    1,701,159
Footnotes (2)
  • [F1]The reporting person is trustee of the Charles R. McCulloch Trust, of which he is a beneficiary. On September 11, 2025, the reporting person caused the trust to distribute 2,000 shares of the Issuer's common stock to a beneficiary of the trust. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. No sale of shares occurred in the transfer.
  • [F2]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Documents

1 file
  • 4
    wk-form4_1757971992.xmlPrimary

    FORM 4